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Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416A382as meniscal progenitor cells (MPC) derived from diseased human
meniscus. Also osteoarthritic cartilage of DDR-1-deﬁcient mice harbors
a progenitor cell population.
Conclusions: Taken together, we propose that speciﬁc progenitor cell
populations found in situ are responsible for tissue regeneration in a
wide variety of cartilage tissues in humans andwill be of importance for
cell biological therapeutic interventions in osteoarthritis.
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Purpose:We are studying the cell based- and pharmaceutical-
approaches for cartilage repair, combined with surgical bone marrow
stimulation technique to supply the cells contributing to wound heal.
Bone marrow tissue has heterogeneous cell-populations, including
hematopoietic stem cells, and we prefer to enhance the cells with as
better chondrogenic ability as possible in order to promote cartilage
repair process. It has been known that direct intra-articular injection of
basic ﬁbroblast growth factor (bFGF) promotes articular cartilage repair
of osteochondral defect in animal model, however bFGF also has an
unfavorable action for clinical application, osteophyte formation. In
vitro studies have shown that the supplementation of bFGF for human
bone marrow derived mesenchymal stem cells (hBMSCs) during
expansion phase maintains the chondrogenic potential as well as
enhance their proliferation. However, the population of hBMSCs sup-
plemented with bFGF has not been investigated enough yet. This study
aimed to analyze some characters, size and MSC markers, of the pop-
ulation of hBMSCs with bFGF.
Methods: Bone marrow aspirates were obtained from healthy donors
by routine iliac crest aspiration with their agreement and seeded to
culture ﬂasks, mixed with 2-fold volume of growth medium containing
15% lot adjusted FBS, supplemented with or without 10ng/ml bFGF
(PeproTech, NJ, USA ). Non-adherent cells were removed at 3days and
culture medium was changed every 3 days. At 11 to 14 days, P0 end,
hBMSCs were passed to P1 and cultured with 5% FBS containing growth
medium, keeping the condition of bFGF. The P1 cells were prepared for
immunocytochemistry and for the conﬁrmation of the chondrogenic
ability. The size of the cells was measured with the automated Coulter
cell counter at the end of P0 and P1. For immunocytochemistry, the cells
at day4 on P1 stage were ﬁxed with 4% PFA, and then Endoglin on cell
surface were stained. The cells harvested at P1 end were used to per-
form pellet culture for 21 days. The histology sections of the pellets
were stained with Safranin-O/Fast green, and the glycosaminoglycan
(GAG) contents were measured and normalized with DNA (GAG/DNA),
to evaluate their chondrogenic ability. The data of two groups, with or
without bFGF on P0 and P1, were compared using unpaired t-test.
Statistical tests were considered signiﬁcant at the level of P < 0.05.
Results: The size of the bFGF supplemented-hBMSCs was signiﬁcantly
smaller than hBMSCs without bFGF at P0 and P1, both. Most of the cells
regardless with bFGF supplementation were expressed Endoglin,
however bFGF supplemented-hBMSCs seemed to express Endoglin
more. The pellets from the cells expanded with bFGF were bigger and
histology of them showed Safranin-O stained more and contained more
GAG/DNA than another as previously reported.
Conclusions: The population of hBMSCs supplemented with bFGF has
some distinct characters, smaller size and probably more expression of
Endoglin than hBMSCs without bFGF. Endoglin has been reported as an
accessory receptor for transforming growth factor-b (TGF-b) and might
modulate the downstream signal molecules, such as smad-1/5/8, of
hBMSCs. Gene expression level of Endoglin needs to be measured, and
other MSC markers as well are going to be investigated. The cells
involving in the cartilage repair would be characterized more, and if we
could target and enhance this kind of the cells with any other agent
than bFGF during cartilage repair process, better cartilage repair might
be acquired.Synovial Tissue Biology & Biochemistry
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Purpose: Over 50% of osteoarthritis (OA) patients show synovial
inﬂammation, even relatively early during the disease. However, if and
how this synovial activation contributes to the irreversible joint path-
ology that characterizes OA, is not known. In the present study we used
microarray analysis of unique synovial tissue samples of early OA
patients and of experimental OA, to identify common pathways that
may determine progression of cartilage damage and osteophyte for-
mation in this disease.
Methods: From 25 patients with knee OA that entered the CHECK
Cohort study Cohort Hip and Cohort Knee) and 6 controls, synovial
biopsies were collected at baseline. CHECK is a prospective 10-year
follow-up study on patients with early osteoarthritis-related com-
plaints initiated by the Dutch Arthritis Association. At baseline and
follow-up, highly standardized radiographs were taken, and analyzed
using the KIDA (Knee Image Digital Analysis) system. Progression was
determined based on change of joint space width (JSW) and osteophyte
size in radiographs, as analyzed using the KIDA (Knee Image Digital
Analysis) system. Synovial samples from baseline were studied using
histology and affymetrix U133-plus-2.0 chips, which were analyzed
using Partek Genomics Suite software and Functional Annotation
Clustering (FAC) was done using DAVID.
Results:Upon histological examination at baseline, we found that lining
thickness and synovitis were enhanced in the CHECK biopsies com-
pared to control synovia. Gene expression proﬁles of control synovia
were compared to our unique set of CHECK synovia. FAC analysis
indicated enrichment of several biological processes and signaling
pathways, including regulation of macrophage differentiation, innate
immune responses, cell migration, TGFb-, BMP- and wnt-signaling. This
indicates activation of the synovium in the CHECK patients compared to
controls. To determine whether any of the regulated genes and path-
ways were predictive for progression of joint damage between baseline
and t¼5, we identiﬁed 13 patients that were marked progressors and
non-progressors, based on JSW (respectively n¼13 vs n¼8) or osteo-
phyte size (respectively n¼10 vs n¼11) at these time points. At baseline,
neither minimum JSW nor osteophyte size differed between the groups.
Approximately 200 genes were expressed more than 2-fold higher in
synovium of osteophyte-progressors, and approximately 100 genes in
the group of JSW-progressors. Among the genes that were differentially
expressed by osteophyte progressors were MMP1, 2, 3, 9 and -14,
whereas in JSW-progressors onlyMMP1was differentially expressed. In
the group of JSW-progressors, macrophage markers like CD14, S100A8,
S100A9, MHC class II genes, and Cxcr2 were positively associated with
progression. This indicates that expression of these factors may predict,
or even be involved in, progression of cartilage damage in OA patients.
The osteophyte-progressors also showed an increase of most of these
markers, but to a far lesser extent. Using FAC we identiﬁed inﬂamma-
tory response, macrophage differentiation, blood vessel formation,
ossiﬁcation and cell migration to be enriched in patients that show
progression of joint space narrowing 5 years later. Blood vessel for-
mation, wound healing, ossiﬁcation and cell proliferation were
enriched in osteophyte-progressors. Histologically, the JSW-progressors
showed a higher thickness of the lining layer and a higher cellularity in
the sublining compared to non-progressors, and compared to osteo-
phyte progressors. Both JSW-progressors and osteophyte-progressors
showed increased vascularisation compared to non-progressors.
Conclusions: These data suggest an active role for the synovium in OA
pathology, and identiﬁes pathways that are likely to be involved. We
found evidence for e difference in underlying processes in the synovium
regarding progression of cartilage damage and progression of osteo-
phyte formation. Fromhistology and the expression data, it appears that
Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416 A383presence of macrophages, especially in the lining layer, is associated
with progression of cartilage damage in OA, whereas synovial expres-
sion of MMPs seems related to progression regarding osteophyte for-
mation.
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Purpose: Synovium is mainly composed of synovial ﬁbroblast (SF) and
macrophage (SM) and a low percentage of other cell types. In osteo-
arthritis (OA) synovial inﬂammation is a key factor associated to pain
and symptoms and to a unique chemokine signature. Aim of the study
was to analyze the role of SF and SM in counteracting the effects due to
adipose stem cell co-culture.
Methods: Good manufacturing practice (GMP)-clinical grade ASC were
isolated from subcutaneous adipose tissue. Synoviocytes were isolated
from synovia of OA patients undergoing total joint replacement. Syn-
oviocytes both at passage 1 (p1) and 5 (p5) were characterized for the
following markers: CD3, CD14, CD16, CD45, CD68, CD90, vimentin,
VCAM-1 by ﬂow cytometry or immunocytochemistry. Secreted
inﬂammatory factors (IL6, CXCL8/IL8, CXCL1/GROa, CCL2/MCP-1, CCL3/
MIP1a, CCL5/RANTES, IL1b, TNFa) were analysed by multiplex bead-
based sandwich immunoassay or ELISA tests on synoviocytes p1 and p5
untreated or co-cultured with ASC in transwell. Macrophages type 1
(M1) and 2 (M2) were also isolated and co-cultured with ASC.
Results: Synoviocytes at p1 (mainly composed of SM and SF) were
approximately 1% positive to CD3, 8% to CD45,10% to CD14,12% to CD16,
8% to CD68, 90% to CD90 while synoviocytes at p.5 (only SF) were
negative to all the markers analyzed except for CD90. Moreover, syno-
viocytes at p. 1 produced a signiﬁcant higher amount of IL6, IL8/CXCL8,
CCL2/MCP-1, CCL3/MIP1a and CCL5/RANTES than at p.5, except CCL3/
MIP1a that was not detected. We conﬁrmed on serial sections of
synovial tissue that CCL3/MIP1a was a marker of SM since the same
cells were also positive to macrophages markers ( CD68, CD16). Inter-
estingly, we conﬁrmed that ASC reduced the release of inﬂammatory
factors only when cultured with p.1 synoviocytes. By contrast, ASC co-
cultured with p5 synoviocytes induced the release of all factors, except
CCL3/MIP1a that was still not released and expressed. Finally, we
demonstrated that ASC effects were strictly dependent by macrophages
type 1 and 2 that decreased the release of IL1b, TNFa and CCL3/
MIP1a.These effects were more evident when macrophages type 1 and
2 were co-cultured in contact.
Conclusions: These data demonstrate that the GMP-ASC effects on OA
synovial inﬂammation is strictly dependent by macrophages. ASC
counteracting effects are mainly mediated by both soluble factors and
cells cross talk.
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Purpose: The purpose of this study was to elucidate the alteration of
gene expression levels of matrix mettalloproteinases (MMPs), ADAMTS-
4 and interleukins (ILs) and protein production of PGE-2, IL-6, and IL-8
in cyclic biomechanical or biochemical stimulation of IL-1b to three-
dimensional cultured tissues of human synovium-derived cells and
further investigate the effects of NSAIDs, dexamethasone, and inhib-
ition of MyD88 using IL-1Ra on the biomechanical or biochemical
stimulation to three-dimensional cultured tissues.
Methods: Human synovium-derived cells were cultured in monolayer,
collected and then seeded to a mechanically reinforced collagen scaf-
fold to construct a three-dimensional cultured tissue. The three-
dimensional cultured tissues were stimulated either biomechanically orbiochemically using a cyclic loading bioreactor at 0.5Hz, 40kPa for 1
hour or 10 ng/ml of IL-1b. The mRNA expressions of MMP-1, MMP-3,
ADAMTS-4, ADMTS-5, IL-6, and IL-8 in the 3-D tissue were quantita-
tively determined by real time RT-PCR at 6 hours after mechanical
loading or IL-1b stimulation. The media were also assayed for protein
production of PGE2, IL-6, and IL-8 by HTRF®. mRNA expression and
protein production were also examined in the presence or absence of
various concentrations of NSAIDs of celecoxib (CEL), indomethacin
(IND) and etodolac (ETD), dexamethasone (DEX) from at a concen-
tration of 1.0 x 10-2 to that of 1.0 x 10 mM or 1mM of IL-1Ra.
Results: Both cyclic biomechanical stimulation and biochemical stim-
ulation of IL-1b statistically signiﬁcantly upregulated gene expressions
of MMP-1, -3, ADAMTS-4 and protein production of PGE2, IL-6 and -8 in
three-dimensional tissues of human synovium-derived cells. NSAIDs
and DEX statistically signiﬁcantly inhibited the upregulation of protein
expression of PGE2 by cyclic biomechanical loading or biochemical
stimulation of IL-1Ra. CEL had an inhibitory effect of upregulated gene
expression of ADAMTS-4 by biomechanical stimulation even at low
concentration of 1.0 x 10-2 mM, whereas IND did in relatively high dose
of 1.0 x 10-1 mM or more. ETD had no effects on ADAMTS-4 gene
